首页> 美国卫生研究院文献>other >The consequences of deglycosylation of recombinant intra-melanosomal domain of human tyrosinase
【2h】

The consequences of deglycosylation of recombinant intra-melanosomal domain of human tyrosinase

机译:人酪氨酸酶的重组黑体内结构域去糖基化的后果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tyrosinase, a melanosomal glycoenzyme, catalyzes initial steps of the melanin biosynthesis. While glycosylation was previously studied in vivo, we present three recombinant mutant variants of human tyrosinase, which were obtained using multiple site-directed mutagenesis, expressed in insect larvae, purified and characterized biochemically. The mutagenesis demonstrated the reduced protein expression and enzymatic activity due to possible loss of protein stability and protein degradation. However, the complete deglycosylation of asparagine residues in vitro, including the residue in position 371, interrupts tyrosinase function, which is consistent with a melanin loss in oculocutaneous albinism type 1 (OCA1) patients.
机译:酪氨酸酶是一种黑色素体糖酶,催化黑色素生物合成的初始步骤。虽然以前已经在体内研究了糖基化,但我们介绍了人类酪氨酸酶的三种重组突变体,这些突变体是使用多位点诱变获得的,在昆虫幼虫中表达,纯化并进行了生化表征。诱变表明由于蛋白质稳定性和蛋白质降解的可能损失,蛋白质表达和酶活性降低。但是,体外天冬酰胺残基(包括371位残基)的完全去糖基化会中断酪氨酸酶功能,这与1型眼皮肤白化病(OCA1)患者的黑色素丢失相符。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号